Modafinil augmentation of antidepressant treatment in depression

Journal of Clinical Psychiatry

Volumn 61, Issue 5, 2000, Pages 378-381

  Menza, Matthew A ^a   Kaufman, Kenneth R ^a   Castellanos, AnaMarietta ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; FLUOXETINE; GABAPENTIN; LAMOTRIGINE; METHYLPHENIDATE; MODAFINIL; NEFAZODONE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; SERTRALINE; TRAZODONE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADULT; AGED; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0034078972     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0510     Document Type: Article

References (21)

1. Clinical Practice Guideline Number 5: Depression in Primary Care, vol 2. Treatment of Major Depression. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551
2. Linet LS. Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine [letter]. Am J Psychiatry 1989;146:803-804
3. Metz A, Shader RI. Combination of fluoxetine with pemoline in the treatment of major depressive disorder. Int Clin Psychopharmacol 1991;6: 93-96
4. Stoll AL, Pillay SS, Diamond L, et al. Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. J Clin Psychiatry 1996;57:72-76
5. Feighner JP, Herbstein J, Damlouji A. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. J Clin Psychiatry 1985;46:206-209
6. Fawcett J, Kravitz HM, Zajecka JM, et al. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression. J Clin Psychopharmacol 1991;11:127-132
7. McClellan KJ, Spencer CM. Modafinil: a review of its pharmacology and clinical efficacy in the management of narcolepsy. CNS Drugs 1998;9: 311-324
8. Bastuji H, Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:695-700
9. Broughton RJ, Fleming JA, George CF, et al. Randomized, double blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997;49:444-451
10. Mignot E, Nishino S, Guilleminault C, et al. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 1994;17:436-437
11. de Sereville JE, Boer C, Rambert F, et al. Lack of presynaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies. Neuropharmacology 1994;33:755-761
12. Lin JS, Roussel B, Akaoka H, et al. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 1992;591:319-326
13. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafminil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci U S A 1996; 93:14128-14133
14. Ferraro L, Tanganelli S, O'Connor WT, et al. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol 1996;306:33-39
15. Gold LH, Balster RL. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology (Berl) 1996;126:286-292
16. Warot D, Corruble E, Payan C, et al. Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine, and placebo. Eur Psychiatry 1993;8:201-208
17. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference [poster]. Presented at the 59th annual College on Problems of Drug Dependance; June 14-15,1997; Nashville, Tenn
18. 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil: studies with experimental animals. Eur J Pharmacol 1990;180:49-58
19. Wong YN, Simcoe D, Hartman LN, et al. A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and toler-ability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 1999;39:30-40
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
21. Hamilton M. Hamilton Depression Scale. In: Guy W, ed. ECDEU Assessment Manual for Psychopharmacology, Revised Edition. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:179-192